TP53 and neoplasm: The simultaneous upregulation of GADD45A, DDIT3, CALR, NME1, and BARD1 indicates that YFSJF activates multiple tumor-suppressive pathways, including the p53/MAPK axis, calcium signaling–mediated immunogenic cell death, and DNA repair regulation [[38], [39], [40]].